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The purpose of this paper is to evaluate the feasibility and clinical dosimetric benefit of an on-line, that is, with the patient in the
treatment position, Adaptive Radiation Therapy (ART) system for prostate cancer treatment based on daily cone-beamCT imaging
and fast volumetric reoptimization of treatment plans. A fast intensity-modulated radiotherapy (IMRT) plan reoptimization
algorithm is implemented and evaluated with clinical cases. The quality of these adapted plans is compared to the corresponding
new plans generated by an experienced planner using a commercial treatment planning system and also evaluated by an in-house
developed tool estimating achievable dose-volume histograms (DVHs) based on a database of existing treatment plans. In addition,
a clinical implementation scheme for ART is designed and evaluated using clinical cases for its dosimetric qualities and eﬃciency.
1. Introduction
During external beam radiation therapy (EBRT) for prostate
cancer patients, interfractional anatomical variations often
occur due to organ motion and/or deformation. Before
the emergence of on-board 3D imaging techniques, these
variations were accounted for by adding margins to the
clinical target volume (CTV) to generate the planning target
volume (PTV) [1, 2]. However, the large deformation/shift
of organs around the prostate and the seminal vesicles can
still lead to incomplete coverage of the target. Figure 1 shows
one such example, due to shape and volume variations of
the bladder and the rectum, the daily CTVs (prostate and
seminal vesicles) exhibit not only the position variations, but
also shape changes, which lead to mismatch between high-
dose region and the daily CTV.
To improve daily CTV coverage, Image-Guided Radi-
ation Therapy (IGRT) has been widely implemented in
clinical practice in recent years. For example, at our insti-
tution, in-room imaging systems such as On-Board Imager
(OBI, Varian Medical Systems, Palo Alto, CA) are used
to guide the on-line patient positioning as well as target
alignment. The patient/target position correction schemes
include 2D-2Dmatching, where on-board orthogonal mega-
voltage (MV)/kilovoltage (kV) images are matched with
digitally reconstructed radiographs (DRRs) from planning
CT data [3–5], and 2D-3D matching, where planning CT
is shifted/rotated in three dimensions to match DRRs with
daily MV/kV images [5–8]. The on-board cone-beam CT
(CBCT) imaging has also led to wide implementation of 3D
soft tissue target matching and repositioning. Such matching
is based on daily contours [9, 10], or grey-scale values of the
on-board and planning 3D images [11–14]. In most clinical
protocols, soft-tissue matching is limited to translational
position corrections due to restricted dimensions on couch
motion.
To further improve daily dose delivery accuracy, on-
line and oﬀ-line plan adaptation or modification utilizing
daily volumetric imaging has been actively studied by several
groups [13–27]. Plan adaptation can account for not only
target position variation, but also the deformation of target
and/or organ-at-risk (OAR) volumes, which occur frequently
during prostate cancer treatment [5]. Some groups have
proposed modification of the multileaf collimator (MLC)
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Figure 1: Daily structure variations of one patient due to bladder and rectum fillings. Shown in the figure are 11 images including 1 planning
CT and 10 cone-beamCT (CBCT) images taken once per day for the first 5 days of treatment (d1–d5), and once per week thereafter (w2–w6).
Colored contours: red—bladder, green—rectum, black—CTV.
segments (aperture shape) directly based on daily structure
shapes and positions [13–17, 19, 20]; while others have
investigated oﬀ-line replanning techniques based on patient-
specific target shape/volume variation trends [21–25, 28].
We have recently developed an on-line plan reoptimization
technique that can correct large anatomical variations and
generate highly conformal daily plans using linear program-
ming models [5, 18].
In this paper, we summarize our approach towards
a clinically applicable on-line adaptive radiation therapy
(ART) system. The paper is divided into four sections.
First, we present the online plan adaptation technique and
demonstrate that the adaptation can be implemented with
speed comparable to the repositioning-based IGRT tech-
niques. Second, the dosimetric benefits of this on-line ART
technique are evaluated against repositioning-based IGRT
techniques with retrospective clinical patient case studies.
Further, plan quality of the adapted plans is compared
with standard IMRT plans of the same anatomy. A dose-
volume histogram (DVH) evaluation tool is also developed
for assessment of the ART plan quality. The actual DVH is
assessed by comparing to predicted achievable DVH based
on daily anatomical structures and the learned anatomy-
DVH correlations from 198 existing treatment plans. Finally,
a clinical implementation scheme is illustrated to maximize
the eﬃciency of the ART strategy by combining both soft-
tissue target matching for simple target position variation
and on-line reoptimization techniques for large anatomical
variations.
2. Methods and Materials
2.1. Fast Reoptimization Algorithm: Technical Feasibility.
Developing a fast replanning algorithm is the first step for
an adaptive radiation therapy program. Recently, several
groups have proposed diﬀerent on-line plan adaptation
methods. They can be categorized into two groups: (1)
for fluence map-based IMRT plans, modifying MLC leaf
positions directly based on changes in anatomical structure
positions and shapes [13, 15, 16] and (2) for direct aperture
optimization- (DAO-) based plans, modifying the aperture
shapes and weights using the projection of the target-organ
deformation information [14, 20]. These methods feature
fast adaptation but are based on manipulating either 2D
fluence maps or discrete 2D beam apertures in the attempt
to approximate the 3D target-OAR geometry variation and
regain the 3D dose conformality of the original plan.
Our approach is to directly reoptimize the fluence map
based on the initial IMRT plan (dose distribution) [5,
18]. This task is divided into the following steps. First,
after the daily image is acquired, deformation fields are
computed from deformable registration between daily CBCT
and planning CT images. The original dose distribution is
then deformed via the deformation fields to provide the goal
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Figure 2: On-line plan adaptation process. After daily CBCT image sets are acquired, they are registered with planning CT image set via
deformable registration, from which a 3D deformation field is generated and is used to deform original dose distribution. The deformed
dose distribution is then fed to the optimization engine as the goal. In less than two minutes, reoptimized beam intensity maps are generated
and final dose is calculated.
dose distribution for the daily anatomy. Structures of interest
(SOI) are contoured by the same attending physician who
contours on the planning CT images or propagated from
planning CT to CBCT via deformation fields. In the early
stages of the ART implementation, CBCT image sets with
physician-contoured structures have been used in our initial
studies. The deformed dose is visually checked for shape
irregularities and excessively high/low dose spots before
being sent to the reoptimization process [5, 18]. A linear
programming model is chosen for its speed and robustness
for the fluence map reoptimization. The aim is to generate
new fluence maps that deliver goal dose distribution. Once
these new intensity maps are generated, dose distributions
are recalculated and dose-volume histograms (DVHs) are
computed and displayed for plan evaluation. Figure 2 illus-
trates the flow of the on-line plan adaptation process.
2.2. Comparison of ART Plans against Repositioned Plans:
Dosimetric Benefits. To evaluate the dosimetric benefits of
the online ART technique, a clinical study is performed
to compare this technique with current repositioning-
based IGRT techniques. This retrospective study includes
6 prostate patient cases, each with 1 planning CT and 5
daily CBCT image sets. For all image sets, SOI including
CTV (prostate + SV) and OARs (bladder and rectum) are
contoured by a single attending physician at our institution.
The urethra is not contoured in this study since it is diﬃcult
to spare in EBRT and is generally not included in the
dosimetric constraints. The PTV is expanded with 5mm
uniform margin from CTV for all plans. The soft-tissue-
matching-based repositioning plans (Soft) are performed by
trying to cover the daily CTV with the initial planning PTV,
simulating standard clinical practice of soft-tissue matching
IGRT. The on-line ART (Adapt) plans are generated using
our in-house developed reoptimization technique [18]. This
plan optimization process is finished within two minutes
for each of the 30 CBCT image sets. DVHs for all SOI are
computed for both techniques. Dosimetric comparisons of
the Adapt versus Soft plans are performed.
2.3. Plan Quality Evaluation for Adaptive Radiation Therapy
(ART). To evaluate the ART plan quality, two methods are
used to assess the dose distributions to the CTVs and the
OARs. One way of evaluating plan quality is to perform
head-to-head comparison between an adapted plan and a
complete new plan designed in the clinical environment for
the same anatomy. This is the step we have taken during
the initial implementation of the online ART technique.
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Figure 3: Flowchart of the quality evaluation tool for the adapted plans. DVHs and SOIs of previous expert plans are used to train the
algorithm to establish the correlation between these two inputs. Once such correlation is learned, achievable/ideal DVHs can be predicted
based on daily SOIs and are compared against actually achieved DVHs.
For each Adapt plan described in section 2b, a complete
new plan (New) is generated using the same CBCT image
and structure set. This new plan is performed with the
clinical treatment planning system (Eclipse) and is used as
the control sample of IMRT planning. The minimum dose to
the hottest 99% of the CTV volume (D99) and the maximal
dose to CTV (Dmax) are used to compare the Adapt plan
quality to the New plan for target coverage. Minimum doses
to the hottest 90% (D90), 50% (D50), and 30% (D30) of the
OAR volumes are chosen as comparison parameters for OAR
sparing, which represent dose sparing in low-, median-, and
high-dose ranges, respectively.
Although head-to-head comparison provides intuitive
and direct assessment based on clinical standards, it is
time consuming. Furthermore, the individual new plan
performed in clinical planning system (Eclipse) uses a
trial-and-error iterative optimization scheme, thus the plan
quality would be dependent of planner’s experience and
time invested and should be performed by expert planners.
To provide standardized plan quality assessment for ART
implementation, a plan evaluation tool is developed to
predict the achievable/ideal dose volume histograms (DVHs)
based on patient anatomy information and the learned
correlation between the anatomy and achieved DVH from
prior treatment plans at our institution (as shown in
Figure 3). First, anatomical information and DVHs of the
PTVs and OARs are extracted from a database of clinical
treatment plans. Principal Component Analysis (PCA) is
used to characterize the DVH and the anatomy structure
information of these existing plans. For a new set of anatomy
structures, this algorithm will predict the achievable/ideal
DVHs for the bladder and the rectum in the given anatomy
(assuming that the PTV coverage remains the same for all
plans). These predicted OAR DVHs provide guidelines to
judge the conformity of the adapted treatment plan.
2.4. Clinical Implementation and Integration of ART. Clinical
implementation and integration of ART should balance
the eﬃciency and the quality of the IMRT treatment. Our
ART implementation utilizes an automatic plan-selection
engine to determine whether repositioning or reoptimization
should be used for the specific daily anatomy, with the
goal of minimizing the frequency of reoptimization while
maintaining uniform CTV coverage and improved OAR
sparing.
The flowchart of the clinical ART implementation is
shown in Figure 4. For each patient, a patient-specific plan
database is created after the completion of initial treatment
planning. Once the daily CBCT is acquired, the CTV and
OARs are contoured by the attending physician or via
deformable registration. The daily CTV is then compared to
the PTVs of all existing plans (1st treatment day only has
original CT plan) in this patient’s plan database, and the
plan that covers >99% daily CTV and minimizes exposure
to the OARs is selected as the best fit. If multiple plans
meet the criteria, the selection engine then chooses the plan
with the smallest PTV. In this way, the selected plan will
provide complete CTV coverage and maximize OAR sparing
simultaneously.
If no plan in the database can meet the criteria,
our replanning process will adapt the initial plan by re-
optimizing the fluence maps (as described in Section 2.1).
The patient is then treated with the adapted plan for that
fraction. After delivery, this adapted plan is added to the plan
database for future fractions.
To evaluate the eﬃcacy of the ART scheme, the daily
plans from this proposed dual-technique scheme (Dual)
are compared with daily reoptimized new plans (New),
which represent the most conformal plans for the anatomy
of the day, and with the currently used repositioning
technique based on soft-tissue target matching plans (Soft).
Such comparison is based on the following key dosimetric
parameters: dose to 99% CTV volume (D99) and doses to
90% (D90), 50% (D50), and 30% (D30) volumes of the
OARs.
The eﬃciency of the ART implementation scheme is
measured as the reduction of frequency of reoptimization
while maintaining the similar CTV coverage and OAR
sparing as the daily New plans. Although the dose warping
and reoptimization process using our algorithm takes about
2min, it is a complicated procedure, and the QA takes
additional time. The adapted plan also needs approval before
delivery. By contrast, existing plans in the patient plan
database are approved plans that can be directly reused
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Figure 4: Flowchart of ART implementation. After a new set of daily SOI is acquired, it is compared to existing plans in the database. If an
existing plan can be found to match the daily anatomy, it is used for that fraction. Otherwise, an adapted plan is generated via reoptimization
for daily treatment and is added to the plan database for future fraction.
without significant change in current clinical flow. Therefore,
reducing the frequency of reoptimization would generally
improve the overall eﬃciency of ART implementation.
All the dose distributions of the Adapt plans are cal-
culated in PLUNC (Department of Radiation Oncology,
University of North Carolina, Chapel Hill, North Carolina),
and dose distributions of the New, the Soft, and the Dual
plans are calculated in Eclipse. The dose calculation engines
in these two systems are diﬀerent, as PLUNC uses delta-SAR-
based method and Eclipse uses pencil-beam convolution
method [18]. The discrepancies between dose distributions
calculated by these two systems are within 2% for 3D
conformal prostate treatment planning. The discrepancies
for IMRT are assumed to be of the same order [18].
Diﬀerence of dose calculated based on CT and CBCT image
might also exist. However, a study at our institution [29]
demonstrated that the diﬀerence is minimal; the MU/cGy
diﬀerences were less than 1% for most phantom cases, and
the isodose distribution from two calculations agreed very
well. Yang et al. also reported that dose computed based on
CT and CBCT agreed to within 1% [30].
3. Results and Discussion
3.1. Adapted Plan by Fast Reoptimization Algorithm. Figure 5
shows one example case where daily anatomical variation
is significant. The original CT plan, the repositioning only
plan (Soft), and the adapted plan (Adapt) are presented. Due
to the significant deformation of the bladder (red contours)
and the rectum (green contours), the position and volume of
daily PTV (black contours) are substantially diﬀerent from
that of the planning PTV on the original CT. Therefore,
even after repositioning, the daily PTV suﬀers significant
underdosage in the superior direction, illustrated by part
of volume not covered by the 95% isodose line in the Soft
plan. In addition, a large portion of rectum is irradiated with
high dose in the Soft plan. Improvement of target coverage
and OAR sparing is achieved in the Adapt plan, with highly
conformal isodose lines to the daily PTV.
The CBCT images used in this study may not have
the same image quality, for example, soft tissue contrast,
compared to the planning CT; therefore, the contouring on
CBCT images is more challenging. To assure consistency, all
the structures on both CT and CBCT images studied in this
paper were retrospectively contoured by a single experienced
attending physician at our institution. We assume the
contours in CBCT are consistent with those in the planning
CT, as well as between fractions.
In this example, the relative locations of prostate and
SV significantly alter the PTV shape, causing discrepancies
between the daily and the planning anatomies. The proposed
reoptimization technique is especially beneficial if large
deformational variation of organs is present. In clinical prac-
tice, such large variation of bladder and/or rectum shape and
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for one treatment fraction. Overlapping of PTV and OARs is caused by the manual expansion from CTV (prostate + rectum) with a 5mm
uniform margin.
volumes may sometimes be reduced by patient instructions
and additional preparations, for example, treating with a full
bladder or emptying rectal gas. The benefit of implementing
ART system is to be further validated against such attempt in
future work.
3.2. Dosimetric Benefit of Adapted Plans over Repositioned
Plans. Figure 6 shows the D99 (minimum dose to CTV)
of the daily CTVs for the 6 clinical cases with 30 total
treatment fractions. The adapted plans (Adapt) from our
fast reoptimization algorithm are evaluated against the
repositioning plans (Soft). As shown, the Adapt plans feature
highly consistent full CTV coverage, demonstrated by all D99
values ranging within (100± 2.5)% of the prescription dose.
The daily D99 of the repositioning technique, on the other
hand, fluctuates substantially, ranging from 45% to 103%.
Overall, the CTV coverage is compromised in 46% of the Soft
plans.
To evaluate OAR sparing between the Adapt and the
Soft plans, the percentage dose diﬀerences delivered to
each volume indices (90%, 50%, and 30% volume, resp.)
are computed for the 30 CBCT cases. Figure 7 shows the
statistical analysis between the Adapt and the Soft plans
for the D90, D50, and D30 of the bladder and the rectum.
Positive values on the y-axis suggest that the reoptimization
technique has reduced dose compared to the repositioning
technique for the corresponding volume, and vice versa. The
red lines, blue boxes, and black dashed lines represent the
median, 50% range and full range of data in each group,
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Figure 6: Dosimetric comparison between the on-line reoptimized
plan (Adapt) and the repositioned plan (Soft). Shown is the
histogram of D99 of CTV for the total 30 CBCT fractions of
6 patients. For each labeled value on the horizontal axis, the
corresponding bin extends to ±2.5% from that value.
respectively. Notches on boxes indicate the intervals of 95%
confidence level. For both bladder and rectum, the median
values are all above zero, and majority of data support
the assumption that reoptimization technique is superior to
repositioning technique, at 95% confidence level.
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Figure 8: Integrated DVH of an example case where false gain in OAR sparing associated with compromised CTV coverage in the Soft plan.
Single-side t-test reveals that the online ART technique is
superior to the soft-tissue-based repositioning technique in
low-dose (P = .0156) and median-dose (P = .0377) ranges
for the bladder, and in low-dose (P < .0001) and high-dose
(P = .0247) ranges for the rectum. The advantage of Adapt
plans over Soft plans in high-dose range for the bladder and
median dose for the rectum is statistically insignificant (P =
.1318 and .1672, resp.).
As seen in Figure 7, for some cases, repositioned plans
feature better OAR sparing than adapted plans. However,
these improvements are often associated with compromised
CTV coverage. Figure 8 shows an example case. In this case,
although the Soft plan provides better sparing for the bladder
and the rectum in the high-dose regions, the CTV coverage
is significantly compromised, with D99 at 84.6%. Such false
OAR sparing with compromised CTV coverage is often seen
in cases with large SV shift due to bladder and/or rectum
deformation.
The random error in daily CTV coverage could be
“washed out” when cumulative dose of all fractions is
calculated [31, 32]. In this study, only fractional dose was
compared since the focus of our online ART system is to
achieve desired dose of each treatment.
3.3. Plan Quality Evaluation. Head-to-head comparison
between the Adapt plans and the New plans is performed
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Figure 9: Head-to-head comparison between reoptimized plans
(Adapt) and the new plans (New), based on Dmax (blue, right) and
D99 (green, left) of CTV. Dose diﬀerences between New and Adapt
plans are calculated by subtracting DNew from DAdapt. Black dots
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of all five fractions. For Pt nos. 2, 3, and 6, since the maximal doses
for majority of fractions are the same, the dots overlap with the 25%
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for the same 6 patients. Figure 9 shows the comparisons
between the Adapt plans and the corresponding New plans
for CTV coverage. Both D99 (green) and Dmax (blue) values
are compared by calculating the diﬀerence between the Adapt
and the New plans. The y-axis indicates the deviation of
the Adapt plans from the New plans. If Adapt plans have
identical D99 and Dmax to the New plans, the deviations
would be zero. Positive value suggests that the Adapt plan
gives higher D99/Dmax compared to the New plan, whereas
negative value indicates that the Adapt plan has lower
D99/Dmax. Overall, Adapt plans oﬀer highly comparable
CTV coverage to New plans. The deviations for D99 are
within −0.3% to 1.4% of the prescription dose, and the
deviations for Dmax. range within−3% to 2%, indicating that
the capability of controlling low-dose (cold spot) and high-
dose (hot spot) regions in the Adapt plans is similar to the
New plans.
Figure 10 compares OAR sparing between the Adapt and
the New plans. The y-axis indicates the diﬀerence in average
D90/D50/D30 between the adapted plans and the new plans.
Positive value suggests that the Adapt plans give higher dose
to a particular volume than the New plan, whereas negative
value indicates better sparing achieved by the Adapt plans.
In general, the Adapt plans are slightly inferior to the New
plans in the median- and high-dose ranges (D50, D30),
demonstrated by positive values being the majority, but in
most cases the discrepancies are within 5%, with the rest
ranging from 8% to 10%. In low-dose range (D90), most of
the Adapt plans are similar to the New plans (within±2.5%),
with one exception in which the Adapt plan shows 8% lower
dose than the New plan.
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(Adapt) and complete new plans performed with clinical treatment
planning system (New), based on averaged D90, D50, and D30
to the bladder and the rectum. y-axis indicates the diﬀerence in
percentage dose between the Adapt and the New plans.
The plan quality evaluation tool is based on machine
learning and is trained using a database of previous 198
expert plans to establish an anatomy-DVH model. As shown
in Figure 11, the evaluation system utilizes the anatomical
structure information from input cases and uses the trained
model to predict the achievable/ideal DVH bands (colored
lines) with 95% confidence levels for 14 test cases. Also
shown are the actual structure DVHs from the Adapt plans
(dashed black lines). Highlighted by black boxes are plans
whose actually achieved DVHs are inferior to the predicted
DVHs, indicating possible improvement on plan quality.
For this proof-of-concept study, the prediction algorithm
implemented in this study is learned from a database of
plans at our institution and demonstrated to be eﬀective
using test cases acquired from the same clinical settings, for
example, imaging device, contouring conventions. However,
care should be taken when implementing this algorithm at
another institution, and the learned model in this study
should be tested and validated for the particular clinical
settings at that institution. Further, the algorithm can be re-
trained to the new plan database of that institution.
3.4. Clinical Implementation and Integration of ART.
Figure 12 shows the histograms of the CTV coverage of the
dual-technique ART plans (Dual), the repositioning IGRT
plans (Soft), and the daily reoptimization plans (New),
respectively. Both the Dual and the New plans exhibit highly
uniform CTV coverage; D99 values for all plans are mostly
concentrated in the 98% to 105% prescription dose range.
OAR sparing of the Dual plans is also compared against
the New and the Soft plans, and the result is illustrated in
Figure 13. Quantitative analysis is based on averaged D90,
D50, and D30 over 10 CBCT fractions for each patient. Each
column in Figure 13 shows the full range (dashed lines), the
25th to 75th percentile range (color boxes), andmedian value
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corresponding bin extends to±2.5% from that value. The Bars from
left to right in the same D99 bin are Dual, New, and Soft.
(red lines) of the D30, D50, and D90 values. Compared to the
Soft plans, both the New and the Dual plans feature smaller
median value and smaller ranges for all three parameters
for both organs, indicating better and more consistent OAR
sparing performance. The New plans represent the control
sample with the most conformal isodose distribution and
therefore have best OAR sparing performance. The Dual
plans oﬀer bladder sparing comparable to the New plans
within 5% variation in both median value and 25th–75th
ranges. For the rectum, the Dual plans have less sparing
compared with the New plans but still show improvement
over the Soft plans. For some patients, the Soft plans have
lower dose to the OAR compared to the New plans, as seen
in D30 for the bladder and D50 for the rectum, but such
apparent sparing is often associated with compromised CTV
coverage, as illustrated in Figure 8.
The eﬃciency of the dual-technique ART implementa-
tion scheme is presented in Figure 14. A total of 18 patients’
simulated treatment processes are followed and analyzed.
Solid black bars are the numbers of patients that are treated
with daily reoptimized plans for a particular fraction, due to
the unsuccessful matching between the daily structures and
the existing plans in the patient-specific database. As more
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Figure 13: Comparison of OAR sparing for the Dual (middle), the New (a), and the Soft (b) plans for 18 patients (total of 180 plans). Each
column indicates the full range (dashed line), 25th∼ 75th percentile range (colored boxes), and the median value (red horizontal lines in
each box) of the D30s, D50s, and D90s.
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Figure 14: Eﬃciency of the dual-technique ART implementation.
Solid black bars indicate the number of patients treated with
reoptimized plans for a particular fraction; light grey bars indicate
the number of patients treated with previous daily reoptimized
plans, and dark bars indicate the number of patients treated with
repositioned original CT plan.
fractions are delivered and more reoptimized plans are
cumulated in the patient plan database, the number of
necessary replanning patients decreases (shorter black bars),
corresponding to the increasing number of patients treated
with existing plans in the database, that is, original CT plan
(dark grey bars) and previous daily reoptimized plans (light
grey bars). The reduction on the need for reoptimization
could benefit institutions treating large number of patients
at the same time, as reusing existing plans from the database
requires minimal change in the current clinical flow.
3.5. Remaining Technical Challenges. This paper provides an
overview of diﬀerent components of our on-going work
towards developing an adaptive radiation therapy system.
There are still several technical challenges that need to
be addressed before this ART system can be clinically
implemented. The online reoptimization process has been
implemented in PLUNC and CPLEX (IBM Corp.), while
currently in the clinical practice at our institution, Eclipse
and ARIA (Varian Medical Systems, Palo Alto, CA) are the
treatment planning and delivery platforms. To integrate the
online reoptimized plan to the clinic, data interfaces between
PLUNC-CPLEX and Eclipse-ARIA need to be configured in
order to transfer the adapted plans. Also, eﬃcient quality
assurance (QA) technique for ART plans needs to be
developed to maximize the eﬃciency of ART. Finally, the
evaluation of the benefit of our ART system should be
extended to radiobiological indices, including EUD, TCP,
and NTCP [18].
4. Conclusion
An on-line Adaptive Radiation Therapy (ART) system for
prostate cancer is developed to eﬃciently account for inter-
fractional organ motion/deformation and improve daily tar-
get coverage and OAR sparing. Our fast plan reoptimization
algorithm produces adapted plans featuring substantially
improved daily target coverage and OAR sparing compared
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to current IGRT technique based on repositioning. The
plan quality of reoptimized plans is comparable to those
generated by full-fledge inverse planning and optimization
in commercial treatment planning system. In addition, a
plan quality evaluation tool, predicting achievable DVH
based on patient’s daily anatomical structure information
and learned anatomy-DVH model, is developed to ensure
that reoptimized plan meets clinical requirement. Finally, the
dual-technique scheme, in which repositioning is expanded
to all delivered plans in the patient-specific plan database
and integrated with reoptimization technique on a need-
based fashion, is clinically feasible, highly eﬃcient, and
dosimetrically beneficial. In conclusion, the on-line ART
system is technically achievable with deformable registration,
fast reoptimization algorithm, and the proper integration of
multiple systems.
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